Skip to content
HowShorted

Coherus Oncology, Inc. short interest in 2019

In 2019, Coherus Oncology, Inc.'s disclosed short interest ran from 12.42% of shares outstanding on 15 Oct 2019 to 14.33% on 31 Dec 2019, a change of +1.91 percentage points. The year's high was 14.33% on 31 Dec 2019 and its low 12.42% on 15 Oct 2019, averaging 13.21% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.97 days on 31 Dec 2019. Full history: Coherus Oncology, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Coherus Oncology, Inc. in 2019

2019 in figures

Start of year
12.42% (15 Oct 2019)
End of year
14.33% (31 Dec 2019)
Change
+1.91 pp
High
14.33% (31 Dec 2019)
Low
12.42% (15 Oct 2019)
Average
13.21%
Highest days to cover
12.97 (31 Dec 2019)
SEC filings marked
10

Every report in 2019

Coherus Oncology, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Oct 201912.42%5.3610-K filed, results (8-K), results (8-K), 10-Q filed, results (8-K), results (8-K), results (8-K), 10-Q filed
31 Oct 201913.04%8.80
15 Nov 201913.08%7.00results (8-K), 10-Q filed
29 Nov 201912.94%9.62
13 Dec 201913.43%9.39
31 Dec 201914.33%12.97

See also: Coherus Oncology, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.